[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_102":103},"en-item",{"_9":10,"_10":11},"kind","item",{"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":25,"_26":27,"_28":29,"_30":31,"_32":31,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":-5,"_48":49,"_50":-5,"_51":-5,"_52":53,"_54":55,"_56":57,"_58":42,"_59":42,"_60":61,"_62":42,"_63":64},"id","b0xx3hofa67dbady67dzk5oer","revision",2,"title","BNS发行与Palantir股价挂钩的高风险证券","originalTitle","BANK OF NOVA SCOTIA (0000009631) (Filer)","summary","BANK OF NOVA SCOTIA (BNS) 发行总额为15,138,000美元的与Palantir Technologies Inc.普通股表现挂钩的附息自动赎回证券，到期日为2029年10月12日。","reason","BNS发行与Palantir股价挂钩的高风险证券，投资者面临本金损失和收益受限风险，且未在交易所上市。","source",{"_12":93,"_94":95,"_9":96,"_97":42,"_98":99,"_100":101},"links",{"_90":91,"_78":92},"publishedAt","2026-10-13T14:13:03.000Z","discoveredAt","2026-10-13T14:43:28.978Z","timelineAt","category","tip","tags",[84,85,86,87,88,89],"stockSymbols",[83],"score",64,"selected",true,"channel","news","story",{"_73":74,"_16":75},"x","readingMode","full","author","language","body",{"_64":77,"_78":-5,"_79":80,"_81":82},"outline",[],"relatedStories",[76],"indexable","markdownAvailable","group",{"_65":66,"_45":67,"_68":69,"_70":71,"_72":71},"hasTranslation","bodyLanguage","zh","factId","ftHRlyvFjxdQ",{"_73":74,"_16":75},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","f6ac0538-799d-4c2a-9aab-acaf435abbe3","BNS发行与Palantir股价挂钩的证券",{"_73":74,"_16":75},"\n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n
\n \n \n	\n 2026年10月定价补充 2026年10月9日注册声明编号 333-298611 根据规则 424(b)(2) 提交（至 2026年10月1日的招股说明书， 2026年10月1日的招股说明书补充和 2026年10月1日的产品补充） \n	\n \n

结构化投资

美国股票中的机会

$15,138,000 与记忆票息一起的或有收入自动可赎回证券，2029年10月12日到期

基于 Palantir Technologies Inc. 普通股的表现。

本金风险证券

附带记忆票息的可自动赎回收益证券（以下简称“证券”）不保证本金的偿还，也不保证定期支付利息。相反，证券为投资者提供了在每个确定日，当标的股票的收盘价大于或等于初始股价的50.00%（我们称之为下行阈值价格）时，获得或有季度票息的机会。如果在任何确定日（包括最终确定日）标的股票的收盘价大于或等于下行阈值价格，BNS将在相关的或有票息支付日支付或有季度票息，以及根据记忆票息功能，针对任何先前确定日的任何未支付的或有季度票息。否则，在该或有票息支付日将不会支付或有季度票息。此外，如果在任何非最终确定日的确定日，标的股票的收盘价大于或等于赎回阈值价格，证券将按每证券（i）面值金额加上（ii）根据记忆票息功能，针对适用确定日和任何先前确定日的任何未支付的或有季度票息的金额自动赎回。一旦证券被赎回，将不再进行任何进一步的支付。然而，如果在任何确定日标的股票的收盘价低于赎回阈值价格，证券将不会被自动赎回，并且如果收盘价低于下行阈值价格，您将不会根据记忆票息功能获得针对适用确定日或任何先前确定日的任何未支付的或有季度票息。因此，如果在每个确定日标的股票的收盘价都低于下行阈值价格，您在整个证券期限内将不会获得任何或有季度票息，并且也不会在证券上获得正回报。投资者必须愿意承担在整个证券期限内可能无法获得任何或有季度票息的风险。此外，如果标的股票的最终股价低于下行阈值价格，BNS将按每证券支付一笔现金，该金额将低于面值金额的50.00%，甚至可能为零，您将按1:1的比例承担最终股价相对于初始股价下跌的风险。在这种情况下，您将损失在证券上的大部分或全部投资。因此，证券不保证到期时本金的回报。投资者不会参与标的股票的增值，也不会在证券期限内获得超过所获得的或有季度票息的回报（如有）。这些证券适合愿意承担全部投资风险并希望以承担在整个证券期限内可能无法获得利息的风险为代价，获得潜在高于市场利率的利息机会的投资者。这些证券是由加拿大丰业银行（“BNS”）发行的高级无担保债务证券。这些证券是作为BNS的高级债券计划（系列A）的一部分发行的债券。

所有证券的付款均受BNS的信用风险影响。如果BNS未能履行付款义务，您可能无法获得证券项下的任何应付款项，并可能损失在证券中的全部投资。这些证券不是担保义务，您不会对任何底层参考资产或资产拥有任何担保权益或任何其他访问权限。

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n	\n	\n
\n 摘要条款 \n	\n \n	\n
\n 发行人： \n	\n 加拿大丰业银行（“BNS”） \n	\n
\n 发行： \n	\n 高级债券计划，系列A \n	\n
\n 底层股票： \n	\n Palantir Technologies Inc.（彭博代码：“PLTR UW”）的普通股 \n	\n
\n 总本金金额： \n	\n $15,138,000 \n	\n
\n 面值本金： \n	\n $1,000.00 每份证券 \n	\n
\n 发行价格： \n	\n $1,000.00 每份证券（见下文“佣金和发行价格”） \n	\n
\n 最低投资： \n	\n $1,000（1份证券） \n	\n
\n 定价日： \n	\n 2026年10月9日 \n	\n
\n 原始发行日： \n	\n 2026年10月15日（定价日后3个工作日）。根据《1934年证券交易法》（经修订）第15c6-1条，二级市场中的交易通常要求在1个工作日（T+1）内结算，除非交易双方明确同意其他方式。因此，希望在证券交付前1个工作日之前在二级市场交易证券的购买者，由于每份证券最初将需要3个工作日（T+3）结算，必须指定替代结算安排，以防止二级市场交易结算失败。 \n	\n
\n 到期日： \n	\n 2029年10月12日，可能因某些市场中断事件而推迟，并按照随附的产品补充文件中的“债券一般条款—市场中断事件”和“—到期日”所述内容进行调整。 \n	\n
\n 提前赎回： \n	\n 如果任何确定日（最终确定日除外）的底层股票收盘价大于或等于赎回阈值价格，证券将在相关确定日之后的第一个附条件股息支付日自动赎回，每份证券的赎回金额等于提前赎回支付金额。一旦证券被赎回，将不再向证券支付任何进一步款项。 \n	\n
\n 提前赎回支付： \n	\n 提前赎回支付金额将等于（i）面值本金加上（ii）适用于相关确定日的附条件季度股息，以及根据记忆股息功能适用于任何先前确定日的任何未付附条件季度股息。 \n	\n
\n 附条件季度股息： \n	\n ▪如果任何确定日的收盘价大于或等于下行阈值价格，我们将在相关附条件股息支付日向每份证券支付40.625美元的附条件季度股息（相当于面值本金的16.25%每年），加上根据记忆股息功能适用于任何先前确定日的任何未付附条件季度股息。 \n ▪如果任何确定日的收盘价小于下行阈值价格，我们将在相关附条件股息支付日不支付附条件季度股息。 \n	\n
\n 记忆股息功能： \n	\n 如果由于在相关确定日标的股票的收盘价低于下行阈值价格，导致在非到期日的或有季度票息支付日未能支付或有季度票息，则如果在对应后续或有季度票息支付日的确定日标的股票收盘价大于或等于下行阈值价格，该或有季度票息将在后续或有季度票息支付日支付。为避免疑义，一旦先前未支付的或有季度票息在后续或有季度票息支付日支付，则该票息不会在任何后续或有季度票息支付日再次支付。 \n 如果在每个确定日标的股票的收盘价均低于下行阈值价格，则在证券期限内您将不会收到任何或有季度票息，且不会从证券中获得正收益。 \n	\n
\n 确定日： \n	\n 2027年1月11日、2027年4月9日、2027年7月9日、2027年10月11日、2028年1月10日、2028年4月10日、2028年7月10日、2028年10月9日、2029年1月9日、2029年4月9日、2029年7月9日和2029年10月9日，具体以非交易日和某些市场中断事件（如附带的产品补充文件中“票据一般条款——市场中断事件”和“——估值日”所述）的推迟情况为准。我们也将2029年10月9日称为最终确定日。 \n	\n
\n 或有票息支付日： \n	\n 2027年1月14日、2027年4月14日、2027年7月14日、2027年10月14日、2028年1月13日、2028年4月13日、2028年7月13日、2028年10月12日、2029年1月12日、2029年4月12日、2029年7月12日和到期日，具体以非营业日和如附带的产品补充文件中“票据一般条款——票息支付日”和“——到期日”所述的推迟情况为准。 \n	\n
\n 到期时的支付： \n	\n ▪如果最终股价大于或等于下行阈值价格： (i) 名义本金金额加上 (ii) 与最终确定日相关的或有季度票息以及根据记忆票息功能与任何先前确定日相关的任何先前未支付的或有季度票息 \n ▪如果最终股价小于下行阈值价格： (i) 名义本金金额乘以 (ii) 股票表现系数 \n 如果最终股价小于下行阈值价格，到期时的支付将低于名义本金金额的50.00%，甚至可能为零。 \n	\n
\n 股票表现系数(1)： \n	\n 最终股价除以初始股价。 \n	\n
\n 行权阈值价格(1)： \n	\n 209.05美元，等于初始股价的100.00% \n	\n
\n 下行阈值价格(1)： \n	\n 104.525美元，等于初始股价的50.00% \n	\n
\n 初始股价(1)： \n	\n 209.05美元，等于定价日标的股票的收盘价 \n	\n
\n 最终股价(1)： \n	\n 标的证券在最终确定日的收盘价。 \n	\n
\n CUSIP / ISIN： \n	\n 06419TS33 / US06419TS339 \n	\n
\n 上市： \n	\n 这些证券不会在任何证券交易所或任何电子通讯网络上上市或展示。 \n	\n
\n 计算代理： \n	\n Scotia Capital Inc. \n	\n
\n 代理： \n	\n Scotia Capital (USA) Inc.（“SCUSA”），BNS的附属公司。参见“关于证券的附加信息 —— 分销计划（利益冲突）的补充信息；二级市场（如有）。” \n	\n
\n 定价日的估计价值： \n	\n 每面值金额为980.86美元，低于上述列出的发行价格。参见本文中的“关于证券的附加信息 —— 证券估计价值的附加信息”以及“风险因素 —— 与估计价值和流动性相关的风险”，从本文第11页开始。您证券的实际价值在任何时候都将反映许多因素，无法准确预测。 \n	\n
\n 佣金和发行价格： \n	\n \n	\n 对公众的定价(2) \n	\n 费用和佣金(2) \n	\n 发行人所得 \n
\n 每证券 \n	\n \n	\n $1,000.00 \n	\n 17.50美元(a) \n + 5.00美元(b) \n $22.50 \n	\n $977.50 \n
\n 总计 \n	\n \n	\n $15,138,000.00 \n	\n $340,605.00 \n	\n $14,797,395.00 \n

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n
\n (1) \n	\n 由计算代理确定，并可能根据“债券一般条款 —— 参考资产收盘价不可用；对参考资产的调整 —— 参考股权收盘价不可用”以及“— 与参考股权相关的反稀释调整”中所述的某些调整事件进行调整，如随附的产品补充文件中所述。 \n
\n (2) \n	\n SCUSA同意按面值购买证券，并作为证券分发的一部分，同意以反映以下内容的承销折扣将证券出售给摩根士丹利史密斯·贝伦 LLC（“摩根士丹利财富管理”）： \n
\n \n	\n (a) \n	\n 摩根士丹利财富管理销售的每1000.00美元面值金额的证券的固定销售佣金为17.50美元，以及 \n
\n \n	\n (b) \n	\n 摩根士丹利财富管理销售的每1000.00美元面值金额的证券的固定结构费用为5.00美元， \n
\n \n	\n 均支付给摩根士丹利财富管理。参见本文中的“关于证券的附加信息 —— 分销计划（利益冲突）的补充信息；二级市场（如有）。” \n

这些证券涉及与普通债务证券投资无关的风险。参见第10页开始的“风险因素”部分。

美国证券交易委员会（“SEC”）或其他任何监管机构均未批准或否决这些证券，也未对本文件、随附的产品补充文件、招股说明书补充文件或招股说明书的准确性或充分性进行评估。与此相反的任何陈述都是刑事犯罪。

这些证券根据《加拿大存款保险公司法》（“CDIC法”）不受到加拿大存款保险公司（“CDIC”）的保险，也不受到美国联邦存款保险公司或加拿大、美国或其他司法管辖区的任何其他政府机构的保险。根据CDIC法，这些证券不是可进行债转股的债务证券。

在决定投资之前，您应将本文与随附的产品补充文件、招股说明书补充文件和招股说明书一起阅读。

\n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n
\n 2026年10月1日的产品补充文件 \n	\n 2026年10月1日的招股说明书补充文件 \n	\n 2026年10月1日的招股说明书 \n

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000 美元附带或有收入的自动可赎回证券，带有记忆票息，2029年10月12日到期

基于 Palantir Technologies Inc. 普通股的表现

本金风险证券

关于 BNS 和证券的更多信息

您应将此定价补充文件与 2026 年 10 月 1 日的招股说明书一起阅读，该文件已由 2026 年 10 月 1 日的招股说明书补充文件和产品补充文件（市场关联票据，系列 A）所补充，该文件涉及我们的高级票据计划，系列 A，这些证券是其中的一部分。本定价补充文件中使用但未定义的术语将在产品补充文件中获得定义。

这些证券可能在多个重要方面与随附的招股说明书、招股说明书补充文件和产品补充文件中描述的条款有所不同。您应仔细阅读此定价补充文件，包括此处引用的文件。如果本定价补充文件与上述任何文件之间存在冲突，以下优先顺序将适用：首先，本定价补充文件；其次，随附的产品补充文件；第三，随附的招股说明书补充文件；最后，随附的招股说明书。您可以通过以下方式在 SEC 网站 www.sec.gov 上访问这些文件（或如果该地址已更改，请查阅我们在 SEC 网站上相关日期的文件）。

本定价补充文件，以及下列列出的文件，包含证券的条款，并取代所有先前或同时期的口头陈述以及任何其他书面材料，包括初步或指示性定价条款、通信、交易想法、实施方案结构、示例结构、宣传册或其他教育材料。您应仔细考虑此处“风险因素”中所述事项，以及随附产品补充文件中的“特定于票据的额外风险因素”以及随附招股说明书补充文件和随附招股说明书中的“风险因素”，因为这些证券涉及与传统债务证券无关的风险。

我们敦促您在考虑投资这些证券时，根据您的具体情况咨询您的投资、法律、税务、会计和其他顾问。

您可以通过以下方式在 SEC 网站 www.sec.gov 上访问这些文件：

♦产品补充文件（市场关联票据，系列 A）2026年10月1日：
http://www.sec.gov/Archives/edgar/data/9631/000183988226048521/bns_424b2-31770.htm

♦招股说明书补充文件2026年10月1日：

http://www.sec.gov/Archives/edgar/data/9631/000183988226048532/bns_424b3-31769.htm

♦招股说明书2026年10月1日：
http://www.sec.gov/Archives/edgar/data/9631/000119312526410029/d175586d424b3.htm

“BNS”、“我们”、“我们”和“我们”仅指加拿大丰业银行，不包括其合并子公司，对“附带收益自动可赎回带记忆票息证券”或“证券”的引用是指本文件中提供的证券。此外，“附带产品补充文件”的引用是指日期为2026年10月1日的BNS产品补充文件，“附带招股说明书补充文件”的引用是指日期为2026年10月1日的BNS招股说明书补充文件，“附带招股说明书”的引用是指日期为2026年10月1日的BNS招股说明书。

在证券发行前，BNS保留更改证券条款或拒绝任何购买要约的权利。如果证券条款有任何变更，BNS将通知您，并要求您在购买时接受这些变更。您也可以选择拒绝这些变更，这种情况下BNS可能会拒绝您的购买要约。

2026年10月第2页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000美元附带收益自动可赎回带记忆票息证券，到期日为2029年10月12日

基于Palantir Technologies Inc.普通股的表现

本金风险证券

投资摘要

附带收益自动可赎回带记忆票息证券
本金风险证券

基于Palantir Technologies Inc.普通股表现的2029年10月12日到期的附带收益自动可赎回带记忆票息证券，我们称之为证券，为投资者提供了一个机会，以获得附带季度票息，该票息金额为每证券40.625美元（相当于面值的16.25%每年），以及根据记忆票息功能，对于任何先前确定日期的未支付附带季度票息，对于每个确定日期，如果收盘价或最终股价（视情况而定）大于或等于初始股价的50.00%，我们称之为下行阈值价格。如果在任何确定日期，基础股票的收盘价低于下行阈值价格，则不会在相关附带票息支付日支付附带季度票息。每个确定日期的附带票息支付日在此封面上有规定，通常为相关确定日期后的第三个营业日，但最终确定日期的附带票息支付日将是到期日。有可能在每个确定日期，基础股票的收盘价低于下行阈值价格，因此您在整个期限内将不会收到任何附带季度票息，也不会在证券上获得正回报。

如果在任何非最终确定日的标的股票收盘价大于或等于认沽阈值价格，证券将自动赎回，每份证券的赎回金额将等于提前赎回支付金额，该金额将包括（i）面值本金金额加上（ii）根据记忆票息功能，就相关确定日及任何之前确定日的未支付的附带季度票息应支付的附带季度票息。如果证券此前未被赎回，且最终股价大于或等于下行阈值价格，到期时的支付金额将包括（i）面值本金金额加上（ii）根据记忆票息功能，就最终确定日及任何之前确定日的未支付的附带季度票息应支付的附带季度票息。然而，如果证券在到期前未被赎回，且最终股价低于下行阈值价格，则不会支付任何附带季度票息，相反，投资者将按1:1的比例承担最终股价相对于初始股价的下跌风险。投资者在到期时收到的支付金额将低于证券面值本金金额的50.00%，甚至可能为零。投资此类证券的投资者必须愿意承担全部投资损失的风险，以及在证券存续期内可能无法获得任何附带季度票息的风险。此外，投资者不会参与标的股票的增值，也不会获得超过在证券存续期内收到的附带季度票息（如有）所代表的回报。

2026年10月第3页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000美元附带收益自动认沽证券（带记忆票息），将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

关键投资理由

这些证券为投资者提供了机会，每份证券可获得相当于40.625美元的附带季度票息（相当于面值本金金额的16.25%每年），加上根据记忆票息功能，就任何之前确定日的未支付附带季度票息，只要在任何确定日的收盘价或最终股价大于或等于初始股价的50.00%，我们称之为下行阈值价格。证券可在到期前以等于提前赎回支付金额的价格赎回，该金额将包括（i）每份证券的面值本金金额加上（ii）就适用的确定日及根据记忆票息功能，就任何之前确定日的未支付附带季度票息应支付的附带季度票息。到期时的支付金额将根据最终股价而有所不同，如下所示：

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n
\n 情景 1 \n	\n \n	\n 在任何非最终确定日的确定日，标的股票的收盘价大于或等于认沽阈值价格。 \n
\n \n	\n \n	\n ￭ \n	\n 这些证券将按每证券等于提前赎回支付金额的金额自动赎回，该金额将为（i）面值本金加上（ii）根据记忆票息功能，针对适用确定日期的或任何之前未支付的与之前确定日期相关的或有季度票息。 \n
\n ￭ \n	\n 投资者不会参与基础股票从初始股价开始的任何增值，也不会在证券期限内获得任何或有季度票息的回报，如果有的话。 \n
\n \n	\n \n	\n \n
\n 情景 2 \n	\n \n	\n 这些证券在到期前不会自动赎回，且最终股价大于或等于下行阈值价格。 \n
\n \n	\n \n	\n ￭ \n	\n 到期时应付的金额为（i）面值本金加上（ii）根据记忆票息功能，针对最终确定日期的或任何之前未支付的与任何之前确定日期相关的或有季度票息。 \n
\n ￭ \n	\n 投资者不会参与基础股票从初始股价开始的任何增值，也不会在证券期限内获得任何或有季度票息的回报，如果有的话。 \n
\n \n	\n \n	\n \n
\n 情景 3 \n	\n \n	\n 这些证券在到期前不会自动赎回，且最终股价低于下行阈值价格。 \n
\n \n	\n \n	\n ￭ \n	\n 到期时应付的金额等于（i）面值本金乘以（ii）股价表现因子。 \n
\n ￭ \n	\n 在本情景中，投资者可能会损失大部分，甚至全部的投资。 \n

投资这些证券涉及重大风险。您可能会损失大部分，甚至全部的投资。任何在证券上的付款，包括提前赎回、或有季度票息或到期时提供的本金还款，均取决于BNS在到期时履行其义务的能力。如果BNS无法履行其义务，您可能无法获得证券下应得的任何金额，您可能会损失在证券上的全部投资。

如果在适用确定日期的基础股票收盘价低于下行阈值价格，则这些证券在或有票息支付日（包括到期日）将不会支付或有季度票息。如果在每个确定日期的基础股票收盘价均低于下行阈值价格，您在证券期限内将不会获得任何或有季度票息，也不会在证券上获得正回报。如果在确定日期的基础股票收盘价低于呼叫阈值价格，这些证券将不会自动赎回。如果证券在到期前未被赎回，并且最终股价低于下行阈值价格，您可能会损失大部分，甚至全部的投资。

2026年10月第4页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 或有收入自动可赎回证券（带记忆票息）将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

投资者适合性

如果满足以下条件，这些证券可能适合您：

您完全了解并愿意接受投资证券的风险，包括可能损失高达100%投资金额的风险

您能够承受重大部分或全部投资损失，并愿意进行可能具有与直接投资于基础股票相同下行市场风险的投资

您认为在每个确定日期基础股票的收盘价将大于或等于下行阈值价格

您了解并接受：(i) 您将不会参与基础股票价格的任何上涨，且任何潜在的正回报仅限于本封面中规定的或有季度票息，以及(ii) 在证券期限内，您可能获得很少或没有或有季度票息

您能够承受到期前证券市场价格波动，这种波动可能与基础股票价格波动相似或更大

您愿意放弃基础股票上支付的任何股息，并且不寻求从该投资中获得保证的当前收入

您愿意投资可能在到期日前赎回的证券，您愿意将此类证券持有至到期，期限约为3年，并接受该证券可能几乎没有或没有二级市场

您了解并愿意接受与基础股票相关的风险

您愿意承担BNS的信用风险，以支付证券的所有款项，您了解如果BNS未能履行其义务，您可能无法获得任何应付金额，包括任何本金偿还

如果以下情况适用，该证券可能不适合您：

您不完全了解或不愿意接受投资证券的风险，包括可能损失高达100%投资金额的风险

您需要一种旨在到期时提供全部或至少部分本金返还的投资

您无法承受重大部分或全部投资损失，或者您不愿意进行可能具有与直接投资于基础股票相同下行市场风险的投资

您认为在某个或多个确定日期基础股票的收盘价可能低于下行阈值价格

您寻求一种参与基础股票价格上涨全部幅度或具有无限回报潜力的投资

您无法承受到期前证券市场价格波动，这种波动可能与基础股票价格波动相似或更大

您希望获得基础股票上支付的任何股息，或者您寻求从该投资中获得保证的当前收入

您无法或不愿意持有可能在到期日前赎回的证券，您 otherwise 无法或不愿意将此类证券持有至到期，期限约为3年，或者您寻求一种会有活跃二级市场的投资

您不了解或不愿意接受与基础股票相关的风险

您不愿意承担BNS的信用风险，以支付证券的所有款项，包括任何本金偿还

2026年10月第5页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 附条件收入自动赎回有记忆票息证券，2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

证券如何运作

以下图示说明了根据（1）收盘价和（2）最终股价的不同情况，证券的潜在结果。

图1：非最终确定日的确定日

图2：如未提前赎回，到期时的支付

有关提前赎回或到期时不同假设情景下的支付的更多信息，请参见“假设示例”，从下一页开始。

2026年10月第6页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 附条件收入自动赎回有记忆票息证券，2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

假设示例

以下示例基于以下条款，仅为假设性（您证券的实际条款见本页封面中所列）。证券的所有支付均受BNS的信用风险影响。

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n
\n 假设初始股价： \n	\n $100.00 \n
\n 假设赎回触发价： \n	\n $100.00，即假设初始股价的100.00% \n
\n 假设下行触发价： \n	\n $50.00，即假设初始股价的50.00% \n
\n 假设附条件季度票息： \n	\n 每证券$40.625（相当于票面本金金额的16.25%每年） \n
\n 票面本金金额： \n	\n 每证券$1,000.00 \n

在示例1和2中，基础股票的收盘价在证券期限内波动，并且在最终确定日之前的某个确定日，基础股票的收盘价大于或等于假设赎回触发价。由于在最终确定日之前的某个确定日收盘价大于或等于赎回触发价，证券将在相关附条件票息支付日自动赎回。在示例3和4中，最终确定日之前的每个确定日的收盘价均低于赎回触发价，因此证券在到期前不会自动赎回，并且在到期时仍然有效。

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n	\n	\n	\n
\n \n	\n 示例1 \n	\n 示例2 \n
\n 确定日 \n	\n 假设收盘价 \n	\n 附条件季度票息 \n	\n 提前赎回支付* \n	\n 假设收盘价 \n	\n 附条件季度票息 \n	\n 提前赎回支付* \n
\n #1 \n	\n $105.00 \n	\n $40.625 \n	\n $1,040.625 \n	\n $45.00 \n	\n $0.00 \n	\n N/A \n
\n #2 \n	\n N/A \n	\n N/A \n	\n N/A \n	\n $60.00 \n	\n $81.25** \n	\n N/A \n
\n #3 \n	\n N/A \n	\n N/A \n	\n N/A \n	\n $120.00 \n	\n $40.625 \n	\n $1,040.625 \n
\n #4-11 \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n
\n 最终确定日 \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n	\n N/A \n
\n 到期时的支付 \n	\n N/A \n	\n N/A \n

* 提前赎回支付包括针对收盘价大于或等于赎回触发价的确定日的未付附条件季度票息，以及根据有记忆票息功能之前未付的附条件季度票息。

** 包括根据有记忆票息功能针对第二个确定日的附条件季度票息和针对第一个确定日的未付附条件季度票息。

▪在示例1中，由于在第一个决定日标的股票收盘价大于或等于赎回阈值价格，证券将自动赎回。由于在该决定日标的股票收盘价大于或等于下行阈值价格，您将在相应的附带票息支付日收到提前赎回金额1040.625美元，该金额包括与该决定日相关的附带季度票息。

在本示例中，提前赎回功能将您的投资期限限制在大约3个月，您可能无法以类似的风险或收益率进行再投资。此外，您将不会参与标的股票的任何增值。在提前赎回后，您将不会收到证券的任何进一步付款。在本示例中，每张证券的总付款额为1040.625美元（证券的总回报率为4.0625%）。\n

2026年10月第7页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000美元附带收益自动赎回证券（带记忆票息），到期日为2029年10月12日

基于Palantir Technologies Inc.普通股的表现

本金风险证券

▪在示例2中，由于在第三个决定日标的股票收盘价大于或等于赎回阈值价格，证券将自动赎回。由于在第一个决定日标的股票收盘价小于下行阈值价格，您在相关附带票息支付日将不会收到与该决定日相关的附带季度票息。由于在第二个决定日标的股票收盘价大于或等于下行阈值价格但小于赎回阈值价格，您将在相关附带票息支付日收到与该决定日相关的附带季度票息以及根据记忆票息功能未支付的与第一个决定日相关的附带季度票息。

此外，由于在第三个决定日标的股票收盘价大于或等于赎回阈值价格（因此也大于下行阈值价格），您将在相关附带票息支付日收到提前赎回金额，计算方式如下：

面值 + 第三个决定日相关的附带季度票息
= 1000.00美元 + 40.625美元 = 1040.625美元

在本示例中，提前赎回功能将您的投资期限限制在大约9个月，您可能无法以类似的风险或收益率进行再投资。如果证券被提前赎回，您将停止收到附带季度票息。此外，尽管标的股票在第三个决定日的收盘价相比初始股价上涨了20.00%，但您的回报将仅限于附带季度票息，您无法从这种增值中获益，如本示例所示。在本示例中，每张证券的总付款额为1121.875美元（证券的总回报率为12.1875%）。\n

\n	\n	\n	\n	\n	\n	\n	\n	\n
\n \n	\n 示例3 \n	\n 示例4 \n
\n 决定日 \n	\n 假设收盘价 \n	\n 附带季度票息 \n	\n 提前赎回付款 \n	\n 假设收盘价 \n	\n 附带季度票息 \n	\n 提前赎回付款 \n	\n
\n #1 \n	\n $45.00 \n	\n $0.00 \n	\n N/A \n	\n $40.00 \n	\n $0.00 \n	\n N/A \n	\n
\n #2 \n	\n $37.50 \n	\n $0.00 \n	\n N/A \n	\n $47.50 \n	\n $0.00 \n	\n N/A \n	\n
\n #3 \n	\n $40.00 \n	\n $0.00 \n	\n N/A \n	\n $42.50 \n	\n $0.00 \n	\n N/A \n	\n
\n #4-11 \n	\n 各种（均低于下行阈值价格和赎回阈值价格） \n	\n $0.00 \n	\n N/A \n	\n 各种（均低于下行阈值价格和赎回阈值价格） \n	\n $0.00 \n	\n N/A \n	\n
\n 最终确定日期 \n	\n $90.00 \n	\n $487.50* \n	\n N/A \n	\n $40.00 \n	\n $0.00 \n	\n N/A \n	\n
\n 到期时支付 \n	\n $1,487.50 \n	\n $400.00 \n

* 最终的或有季度票息（以及根据记忆票息功能之前未支付的或有季度票息）将在到期时支付。

2026年10月第8页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000美元具有记忆票息的或有收入自动赎回证券，将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

示例3和4说明了根据最终股价每证券的到期支付情况。

▪在示例3中，最终确定日期之前的每个确定日期的标的股票收盘价均低于下行阈值价格和赎回阈值价格。因此，您在任何相关或有票息支付日均不会收到或有季度票息，且证券在到期前不会被自动赎回。由于最终确定日期的收盘价大于或等于下行阈值价格，到期时您将收到约定的本金金额以及与最终确定日期相关的或有季度票息以及根据记忆票息功能之前未支付的或有季度票息。您的到期支付计算如下：

约定本金金额 + 与最终确定日期相关的或有季度票息 + 之前未支付的与先前确定日期相关的或有季度票息
= 1,000.00美元 + 40.625美元 + 446.875美元 = 1,487.50美元

在这个示例中，尽管最终股价相比初始股价下降了10.00%，您仍将收到每证券的约定本金金额以及与最终确定日期相关的或有季度票息以及根据记忆票息功能之前未支付的或有季度票息，总计每证券到期支付1,487.50美元（证券的总回报率为48.75%）。

▪在示例4中，证券整个期限内每个确定日期的标的股票收盘价均低于下行阈值价格和赎回阈值价格。因此，在证券期限内您不会收到任何或有季度票息，且证券在到期前不会被自动赎回。此外，由于最终股价低于下行阈值价格，您将在到期时收到如下计算的现金支付：

约定本金金额 × 股价表现系数
= 1,000.00美元 × (40.00美元 / 100.00美元) = 400.00美元

在这个示例中，您的到期支付明显低于约定本金金额，您将在到期时收到每证券400.00美元的总现金支付（证券损失60.00%）。

投资证券涉及重大风险。这些证券与普通债务证券不同，BNS不一定有义务偿还您在证券中的全部投资金额。如果在到期前未赎回证券，且最终股价低于下行阈值价格，您将按1:1的比例承担标的股票从初始股价到最终股价的负面表现。在这种情况下，您在到期时收到的金额将少于面值金额的50.00%，您可能会损失在证券中的全部投资。

如果在相关决定日标的股票的收盘价低于下行阈值价格，这些证券在附带的红利支付日（包括到期日）将不会支付附带的季度红利。如果在每个决定日标的股票的收盘价都低于下行阈值价格，您在整个期限内将不会收到任何附带的季度红利，也不会从这些证券中获得正回报。除非在相关决定日标的股票的收盘价高于或等于赎回阈值价格，否则这些证券不会针对任何决定日自动赎回。

根据BNS履行到期义务的能力，将向这些证券支付的任何款项（包括本金的偿还）都可能受到影响。如果BNS未能履行其付款义务，您可能无法获得根据这些证券应得的任何款项，并可能损失在这些证券中的全部投资。

2026年10月第9页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

15,138,000美元附带收益自动赎回证券（带记忆收益）将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

风险因素

以下是一些针对证券投资者的关键风险因素的非详尽列表。有关这些及其他风险的进一步讨论，请阅读随附的产品补充文件中的“特定于票据的额外风险因素”部分以及随附的招股说明书补充文件和招股说明书中的“风险因素”部分。我们建议您就投资这些证券咨询您的投资、法律、税务、会计及其他顾问。

与回报特性相关的风险

￭到期时亏损的风险。这些证券与普通债务证券不同，BNS在到期时不一定偿还证券的面值金额。如果在到期前未赎回证券，BNS仅在标的股票的最终股价高于或等于下行阈值价格时，才会以现金形式偿还您证券的面值金额，并且仅在到期时进行此类支付。如果在到期前未赎回证券，且最终股价低于下行阈值价格，您将按每证券获得少于面值金额的现金支付，并且将按1:1的比例承担最终股价相对于初始股价的下跌风险。您可能会损失在证券中的全部投资。

￭仅在到期时支付约定的本金金额。如果您在到期前未赎回证券，您应愿意将证券持有至到期。如果您能在二级市场提前出售证券，即使当时标的股票的价格大于或等于下行阈值价格，您可能仍需以低于投资金额的价格出售证券。

￭您可能无法获得任何或有季度票息。BNS不会必然对证券进行定期支付。只有在相关确定日期标的股票的收盘价大于或等于下行阈值价格时，才会在或有票息支付日支付或有季度票息，以及根据记忆票息功能针对任何先前确定日期的任何未支付或有季度票息。如果在任何确定日期标的股票的收盘价低于下行阈值价格，BNS将在相关或有票息支付日不支付或有季度票息；如果在每个后续确定日期标的股票的收盘价都低于下行阈值价格，您在任何后续或有票息支付日（包括到期日）都不会获得该或有季度票息。如果在每个确定日期标的股票的收盘价都低于下行阈值价格，您在整个期限内将不会获得任何或有季度票息，且您也不会从证券中获得正收益。通常，这种或有季度票息的不支付与您的证券出现更大本金损失风险的时期相吻合。

￭标的股票的预期波动性越大，通常意味着或有季度票息越高，并且在定价日对标的股票最终股价可能低于最终确定日期下行阈值价格的预期也越高。标的股票的预期波动性越大，意味着在定价日对标的股票最终股价可能低于最终确定日期下行阈值价格的预期也越高。“波动性”指的是标的股票价格变化的频率和幅度。这种更高的预期风险通常会反映在比预期波动性较低时更高的或有季度票息率上。然而，尽管或有季度票息是在定价日根据标的股票的波动性（部分基于我们的内部模型计算）设定的，但标的股票的波动性在证券期限内可能会发生显著变化。标的股票的价格可能会大幅下跌，这可能导致您在证券上的投资损失大部分或全部。

证券在提前赎回的情况下会面临再投资风险。如果在任何非最终确定日的确定日，标的股票的收盘价大于或等于赎回阈值价格，证券将在到期前自动赎回，且您在相关或有季度票息支付日后将不再收到任何或有季度票息。相反，如果在任何确定日的收盘价低于赎回阈值价格，证券将不会被自动赎回，这通常意味着您的证券面临更大的本金损失风险。证券可能早在第一个或有季度票息支付日就被赎回，这可能会将您的投资期限限制在大约3个月。如果证券在到期前被赎回，不能保证您能够以类似风险水平的可比收益率重新投资证券的收益。此外，如果您能够将这些收益重新投资于与证券类似的资产，您将产生交易成本，且该投资的原始发行价格很可能包含某些内置成本，如经销商折扣和对冲成本。

任何或有季度票息（如有）仅基于收盘价或最终股价（以适用者为准）。在相关确定日，标的股票的收盘价或最终股价（以适用者为准）将决定是否在或有票息支付日支付任何或有季度票息。因此，您直到相关确定日才能知道是否将收到任何或有季度票息。如果您在或有票息支付日未收到或有季度票息，您直到对应于该或有票息支付日的后续确定日才能知道是否会在之后的任何或有票息支付日根据记忆票息功能收到该或有季度票息。此外，如果您在或有票息支付日未收到或有季度票息，并且在每个后续确定日（包括最终确定日）标的股票的收盘价低于下行阈值价格，您将不会收到与该确定日相关的任何或有季度票息，即使在证券期限内其他日期标的股票的收盘价高于下行阈值价格。

2026年10月第10页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 或有收益自动赎回证券（带记忆票息），将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

￭您在证券上的潜在回报是有限的，您不会参与基础股票的任何增值，您也不会在证券存续期内收到任何 contingent quarterly coupons（如有）之外的回报。证券的回报潜力仅限于 contingent quarterly coupons，无论基础股票的价格是否上涨。您在证券上的回报将根据到期前或提前赎回前满足 contingent quarterly coupon 要求的确定日期数量而有所不同。此外，如果证券在到期前被赎回，您将不会收到任何 contingent quarterly coupons 或任何与适用的 contingent coupon 支付日期之后的确定日期相关的其他付款，您在证券上的回报可能低于证券到期时的回报。如果证券在到期前未被赎回，即使您无法参与基础股票价格的任何增值，您也可能面临基础股票价格的贬值。因此，投资于证券的回报可能低于直接投资于基础股票的回报。此外，作为证券的持有者，您不会收到基础股票的任何股息或分配，并且您不会拥有基础股票持有者的投票权或其他任何权利。

与基础股票特性相关的风险

￭证券受与投资单一股票相关的风险影响。基础股票的价值可能因与基础股票及其发行人（“基础股票发行人”）相关的特定因素而大幅上涨或下跌，例如股价波动、收益、财务状况、公司、行业和监管发展、管理层变动和决策以及其他事件，以及一般市场因素，如整体股市波动和水平、利率以及经济、政治和其他状况。作为证券的投资者，您应自行调查基础股票发行人和基础股票。有关基础股票的更多信息，请参见下面的“关于基础股票的信息”以及本节中提到的基础股票发行人的 SEC 文件。我们建议您查阅基础股票发行人定期向 SEC 提交的财务和其他信息。

￭无法保证证券中隐含的投资观点会取得成功。无法预测标的股票的价值会涨或跌以及涨跌幅度，也无法保证在任何确定日标的股票的收盘价会高于或等于下行阈值价格，或者如果证券在到期前未被赎回，最终确定日的最终股价会高于或等于下行阈值价格。标的股票的价值将受到影响标的股票及其发行人的复杂且相互关联的政治、经济、金融和其他因素的影响。您应愿意接受一般股票和特别是标的股票的下行风险，并承担在证券中损失大部分或全部投资的风险。

￭BNS与标的股票发行人之间没有任何关联。标的股票发行人不是我们的关联方，与此次发行没有任何关系，也无义务在采取可能影响证券价值的任何公司行为时考虑您的利益。我们未对标的股票进行任何尽职调查。

与估值和流动性相关的风险

￭在定价时（您的证券条款在定价日确定时），BNS对证券的初始估值低于证券的发行价。BNS对证券的初始估值仅是一个估算。证券的发行价高于BNS的初始估值。证券的发行价与BNS初始估值之间的差额反映了与销售和结构化证券以及对证券项下义务对冲相关的成本。因此，证券的经济条款对您来说不如这些费用未支付或更低时有利。

￭无论何时，BNS或SCUSA对证券的估值都不是根据信用利差或BNS为其常规固定利率债务证券支付的借款利率来确定的。BNS在定价时对证券的初始估值以及SCUSA在任何时间对证券的估值都是根据BNS的内部资金利率来确定的。用于确定证券估值的内部资金利率通常代表对BNS常规固定利率债务证券的信用利差以及BNS为其常规固定利率债务证券支付的借款利率的折扣。这一折扣基于多种因素，包括BNS对证券的资金价值的看法，以及与BNS常规固定利率债务相比，证券的更高发行、运营和持续负债管理成本。如果使用BNS常规固定利率债务证券的信用利差所隐含的利率，或BNS为其常规固定利率债务证券支付的借款利率，BNS预计证券的经济条款会对您更有利。因此，对证券使用内部资金利率会提高证券在任何时间的估值，并对证券的经济条款产生不利影响。

2026年10月第11页

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 附带记忆票息的或有收入自动赎回证券，将于2029年10月12日到期

基于Palantir Technologies Inc.普通股的表现

本金风险证券

￭BNS对证券的初始估算价值不代表证券的未来价值，可能与其他方（包括SCUSA）的估算不同。BNS对证券的初始估算价值是在设定证券条款时参考其内部定价模型确定的。这些定价模型考虑了某些因素，如定价日BNS的内部资金成本、证券的预期期限、当时存在的市场状况和其他相关因素，以及BNS对市场参数的假设，这可能包括基础股票的波动率、股息率、利率和其他因素。不同的定价模型和假设（包括SCUSA使用的模型和假设）可能会给出与BNS初始估算价值不同的估值，甚至可能是显著更低的估值。因此，如果SCUSA做市（它没有义务这样做），它可能以显著低于BNS初始估算价值的价格买入或卖出您的证券。此外，未来的市场状况和其他相关因素可能会发生变化，任何假设都可能被证明是错误的。

￭证券的流动性有限。证券不会在任何证券交易所或自动报价系统上上市。因此，可能几乎没有或没有二级市场。BNS的任何附属公司（包括SCUSA）有意但没有义务为证券做市。即使存在二级市场，它可能也不会提供足够的流动性，使您能够轻松交易或出售证券。由于我们预计其他经纪自营商不会参与证券的二级市场，您可能能够交易证券的价格很可能取决于SCUSA愿意从您手中购买证券的价格（如果有的话）。如果在任何时候SCUSA不为证券做市，那么证券可能根本没有二级市场。因此，您应愿意持有证券至到期。

￭SCUSA 买入或卖出您的证券的价格（如果 SCUSA 做市，但它没有义务这么做）将基于 SCUSA 对您证券的估值。SCUSA 对证券的估值是根据其定价模型确定的，并考虑了 BNS 的内部资金利率。SCUSA 在二级市场最初买入或卖出您的证券的价格（如果 SCUSA 做市，但它没有义务这么做）在定价时将高于 SCUSA 对您证券的估值。根据 SCUSA 与分销参与方的约定，这一溢价预计将在“关于证券的额外信息——分销计划（利益冲突）；二级市场（如有）”中规定的期限内降至零。此后，如果 SCUSA 买入或卖出您的证券，它将根据当时参考 SCUSA 的定价模型确定的估计值进行交易。SCUSA 在任何时间买入或卖出您的证券的价格还将反映其当时对类似规模的结构化票据交易的买卖价差。如果 SCUSA 根据 BNS 的信用利差或 BNS 为其传统固定利率债券证券（而非 BNS 的内部资金利率）支付的借款利率来计算其对您证券的估值，那么 SCUSA 买入或卖出您的证券的价格（如果 SCUSA 做市，但它没有义务这么做）可能会显著降低。

SCUSA’s pricing models consider certain variables, including principally BNS’ internal funding rate, interest rates (forecasted, current and historical rates), the volatility of the underlying stock, price-sensitivity analysis and the time to maturity of the securities. These pricing models are proprietary and rely in part on certain assumptions about future events, which may prove to be incorrect. As a result, the actual value you would receive if you sold your securities in the secondary market, if any, to others may differ, perhaps materially, from the estimated value of the securities determined by reference to SCUSA’s models, taking into account BNS’ internal funding rate, due to, among other things, any differences in pricing models or assumptions used by others. See “— The price of the securities prior to maturity will depend on a number of factors and may be substantially less than the stated principal amount” herein.

In addition to the factors discussed above, the value and quoted price of the securities at any time will reflect many factors and cannot be predicted. If SCUSA makes a market in the securities, the price quoted by SCUSA would reflect any changes in market conditions and other relevant factors, including any deterioration in BNS’ creditworthiness or perceived creditworthiness. These changes may adversely affect the value of the securities, including the price you may receive for the securities in any market making transaction. To the extent that SCUSA makes a market in the securities, the quoted price will reflect the estimated value determined by reference to SCUSA’s pricing models at that time, plus or minus SCUSA’s then current bid and ask spread for similar sized trades of structured notes (and subject to the declining excess amount described above).

Furthermore, if you sell your securities, you will likely be charged a commission for secondary market transactions, or the price will likely reflect a dealer discount. This commission or discount will further reduce the proceeds you would receive for your securities in a secondary market sale.

There is no assurance that SCUSA or any other party will be willing to purchase your securities at any price and, in this regard, SCUSA is not obligated to make a market in the securities. See “— The securities have limited liquidity” herein.

￭The price of the securities prior to maturity will depend on a number of factors and may be substantially less than the stated principal amount. The price at which the securities may be sold prior to maturity will depend on a number of factors. Some of these factors include, but are not limited to: (i) actual or anticipated changes in the price of the underlying stock over the full term of the securities, (ii) volatility of the price of the underlying stock and the market's perception of the future volatility of the underlying stock, (iii) changes in interest rates generally, (iv) any actual or anticipated changes in our credit ratings or credit spreads, (v) dividend yields on the underlying stock and (vi) time remaining to maturity. In particular, because the provisions of the securities relating to the contingent quarterly coupons and the payment at maturity behave like options, the value of the securities will vary in ways which are non-linear and may not be intuitive.

Depending on the actual or anticipated price of the underlying stock and other relevant factors, the market value of the securities may decrease and you may receive substantially less than the stated principal amount if you sell your securities prior to maturity regardless of the price of the underlying stock at such time.

October 2026 Page 12

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

See “Additional Risk Factors Specific to the Notes — Risks Relating to Liquidity — The Market Value of Your Notes May Be Influenced by Many Unpredictable Factors” in the accompanying product supplement.

Risks Relating to General Credit Characteristics

￭Payments on the securities are subject to the credit risk of BNS. The securities are senior unsecured debt obligations of BNS and are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment of principal, depends on the ability of BNS to satisfy its obligations as they come due. As a result, BNS’ actual and perceived creditworthiness may affect the market value of the securities. If BNS were to default on its obligations, you may not receive any amounts owed to you under the terms of the securities and you could lose your entire investment in the securities.

Risks Relating to Hedging Activities and Conflicts of Interest

￭Hedging activities by BNS and SCUSA may negatively impact investors in the securities and cause our respective interests and those of our clients and counterparties to be contrary to those of investors in the securities. We, SCUSA or one or more of our other affiliates has hedged or expects to hedge our obligations under the securities. Such hedging transactions may include entering into swap or similar agreements, purchasing shares of the underlying stock and/or purchasing futures, options and/or other instruments linked to the underlying stock. We, SCUSA or one or more of our other affiliates also expects to adjust the hedge by, among other things, purchasing or selling any of the foregoing, and perhaps other instruments linked to the underlying stock, at any time and from time to time, and to unwind the hedge by selling any of the foregoing on or before the final determination date. We, SCUSA or one or more of our other affiliates may also enter into, adjust and unwind hedging transactions relating to other basket- or equity-linked securities whose returns are linked to changes in the price of the underlying stock. Any of these hedging activities may adversely affect the price of the underlying stock and therefore the market value of the securities and the amount you will receive, if any, on the securities.

You should expect that these transactions will cause BNS, SCUSA or our other affiliates, or our clients or counterparties, to have economic interests and incentives that do not align with, and that may be directly contrary to, those of an investor in the securities. None of BNS, SCUSA or any of our other affiliates will have any obligation to take, refrain from taking or cease taking any action with respect to these transactions based on the potential effect on an investor in the securities, and any of the foregoing may receive substantial returns with respect to these hedging activities while the value of, and return on, the securities declines.

￭The calculation agent can make antidilution and other adjustments that may adversely affect the market value of, and any amounts payable on, the securities. For antidilution and certain other events affecting the underlying stock, the calculation agent may make adjustments to the initial share price, share performance factor, call threshold price, downside threshold price, closing price and/or final share price, as applicable, and any other term of the securities. However, the calculation agent will not make an adjustment in response to every corporate event that could affect the underlying stock. If an event occurs that does not require the calculation agent to make an adjustment, the market value of, and any payment on, the securities may be materially and adversely affected. In addition, all determinations and calculations concerning any such adjustments will be made by the calculation agent. You should be aware that the calculation agent may make any such adjustment, determination or calculation in a manner that differs from that discussed in the accompanying product supplement or this document as necessary to achieve an equitable result. Following certain reorganization events relating to the underlying stock issuer where such issuer is not the surviving entity, the determination as to whether the securities are redeemed early and/or the amount you receive at maturity may be based on the equity security of a successor to the underlying stock issuer in combination with any cash or any other assets distributed to holders of the underlying stock in such reorganization event. If the underlying stock is delisted or otherwise suspended from trading, the calculation agent will determine the closing price of the underlying stock in good faith and in a manner designed to achieve a commercially reasonable result, which may include deeming the closing price of the underlying stock on the trading day immediately preceding such event to be the closing price on every remaining trading day to and including the final determination date. The occurrence of any antidilution or reorganization event and the consequent adjustments may materially and adversely affect the value of, and any amounts payable on, the securities. For more information, see the sections as described under “General Terms of the Notes — Unavailability of the Closing Value of a Reference Asset; Adjustments to a Reference Asset — Unavailability of the Closing Value of a Reference Equity” and “— Anti-Dilution Adjustments Relating to a Reference Equity” in the accompanying product supplement.

October 2026 Page 13

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

￭We, SCUSA and our other affiliates regularly provide services to, or otherwise have business relationships with, a broad client base, which has included and may include us and the underlying stock issuer and the market activities by us, SCUSA or our other affiliates for our or their own respective accounts or for our clients could negatively impact investors in the securities. We, SCUSA and our other affiliates regularly provide a wide range of financial services, including financial advisory, investment advisory and transactional services to a substantial and diversified client base. As such, we each may act as an investor, investment banker, research provider, investment manager, investment adviser, market maker, trader, prime broker or lender. In those and other capacities, we, SCUSA and/or our other affiliates purchase, sell or hold a broad array of investments, actively trade securities (including the securities or other securities that we have issued), the underlying stock, derivatives, loans, credit default swaps, indices, baskets and other financial instruments and products for our or their own respective accounts or for the accounts of our customers, and we will have other direct or indirect interests, in those securities and in other markets that may not be consistent with your interests and may adversely affect the price of the underlying stock and/or the value of the securities. You should assume that we or they will, at present or in the future, provide such services or otherwise engage in transactions with, among others, us and underlying stock issuer, or transact in securities or instruments or with parties that are directly or indirectly related to these entities. These services could include making loans to or equity investments in those companies, providing financial advisory or other investment banking services, or issuing research reports. Any of these financial market activities may, individually or in the aggregate, have an adverse effect on the price of the underlying stock and the market for your securities, and you should expect that our interests and those of SCUSA and/or our other affiliates, clients or counterparties, will at times be adverse to those of investors in the securities.

You should expect that we, SCUSA, and our other affiliates, in providing these services, engaging in such transactions, or acting for our or their own respective accounts, may take actions that have direct or indirect effects on the securities or other securities that we may issue, the underlying stock or other securities or instruments similar to or linked to the foregoing, and that such actions could be adverse to the interests of investors in the securities. In addition, in connection with these activities, certain personnel within us, SCUSA or our other affiliates may have access to confidential material non-public information about these parties that would not be disclosed to investors in the securities.

We, SCUSA and our other affiliates regularly offer a wide array of securities, financial instruments and other products into the marketplace, including existing or new products that are similar to the securities or other securities that we may issue, the underlying stock or other securities or instruments similar to or linked to the foregoing. Investors in the securities should expect that we, SCUSA and our other affiliates offer securities, financial instruments, and other products that may compete with the securities for liquidity or otherwise.

￭Activities conducted by BNS and its affiliates may impact the market price of the underlying stock and the value of the securities. Trading or transactions by BNS, SCUSA or our other affiliates in the underlying stock, listed and/or over-the-counter options, futures, exchange-traded funds or other instruments with returns linked to the performance of the underlying stock may adversely affect the price of the underlying stock and, therefore, the market value of the securities and the likelihood of a contingent quarterly coupon being paid on any contingent coupon payment date. See “— Hedging activities by BNS and SCUSA may negatively impact investors in the securities and cause our respective interests and those of our clients and counterparties to be contrary to those of investors in the securities” for additional information regarding hedging-related transactions and trading.

￭The calculation agent will have significant discretion with respect to the securities, which may be exercised in a manner that is adverse to your interests. The calculation agent will be an affiliate of BNS. The calculation agent will determine whether the contingent quarterly coupon is payable to you on any contingent coupon payment date and the payment at maturity of the securities, if any, based on observed closing prices of the underlying stock. The calculation agent can postpone the determination of the closing price or final share price (and therefore the related contingent coupon payment date or maturity date, as applicable) if a market disruption event occurs and is continuing with respect to the underlying stock on any determination date (including the final determination date).

￭BNS and its affiliates may publish research or make opinions or recommendations that are inconsistent with an investment in the securities. BNS, SCUSA and our other affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities, or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions or recommendations expressed by BNS, SCUSA or our other affiliates may not be consistent with each other and may be modified from time to time without notice. Investors should make their own independent investigation of the merits of investing in the securities and the underlying stock to which the securities are linked.

Risks Relating to Canadian and U.S. Federal Income Taxation

￭Uncertain tax treatment. Significant aspects of the tax treatment of the securities are uncertain. You should consult your tax advisor about your tax situation. See “Additional Information About the Securities — Tax Considerations” and “— Material Canadian Income Tax Consequences” herein.

October 2026 Page 14

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

Information About the Underlying Stock

All disclosures contained in this document regarding the underlying stock are derived from publicly available information. BNS has not conducted any independent review or due diligence of any publicly available information with respect to the underlying stock. You should make your own investigation into the underlying stock.

Palantir Technologies Inc.

According to publicly available information, Palantir Technologies Inc. (“Palantir”) builds software platforms for government and commercial institutions. Information filed by Palantir with the SEC can be located by reference to its SEC file number: 001-39540, or its CIK Code: 0001321655. Palantir’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol “PLTR”.

Historical Information

The closing price of Palantir on October 9, 2026 was $209.05. The graph below shows the closing prices of Palantir for each day from January 1, 2021 to October 9, 2026. The dotted lines represent the downside threshold price of $104.525 and the call threshold price of $209.05, which are equal to 50.00% and 100.00%, respectively, of the initial share price. We obtained the information in the graph below from Bloomberg Professional® service (“Bloomberg”), without independent verification. The closing prices may be adjusted by Bloomberg for corporate actions such as stock splits, public offerings, mergers and acquisitions, spin-offs, delistings and bankruptcy. BNS has not undertaken an independent review or due diligence of any publicly available information obtained from Bloomberg. The historical performance of Palantir should not be taken as an indication of its future performance, and no assurance can be given as to the price of Palantir at any time, including the determination dates.

\n \n \n \n \n \n \n

The Common Stock of Palantir Technologies Inc. –
Daily Closing Prices January 1, 2021 to October 9, 2026

This document relates only to the securities offered hereby and does not relate to the underlying stock or other securities linked to the underlying stock. We have derived all disclosures contained in this document regarding the underlying stock from the publicly available documents described in the preceding paragraphs. In connection with the offering of the securities, none of us or any of our affiliates have participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying stock. Neither we nor the agent makes any representation that such publicly available documents or any other publicly available information regarding the underlying stock is accurate or complete. Furthermore, we cannot give any assurance that all events occurring prior to the date hereof (including events that would affect the accuracy or completeness of the publicly available documents described above) that would affect the trading price of the underlying stock (and therefore the price of the underlying stock at the time we price the securities) have been publicly disclosed. Subsequent disclosure of any such events or the disclosure of or failure to disclose material future events concerning the underlying stock could affect the value received with respect to the securities and therefore the value of the securities.

Neither the issuer nor any of its affiliates makes any representation to you as to the performance of the underlying stock.

October 2026 Page 15

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

Additional Information About the Securities

Please read this information in conjunction with the summary terms on the front cover of this document.

\n	\n	\n	\n
\n Additional Provisions: \n	\n \n	\n
\n Record date: \n	\n The record date for each contingent coupon payment date shall be the date that is one business day prior to such scheduled contingent coupon payment date. \n	\n
\n Trustee: \n	\n Computershare Trust Company, N.A. \n	\n
\n Calculation agent: \n	\n Scotia Capital Inc. \n	\n
\n Trading day: \n	\n As specified in the product supplement under “General Terms of the Notes — Special Calculation Provisions — Trading Day” \n	\n
\n Business day: \n	\n As specified in the product supplement under “General Terms of the Notes — Special Calculation Provisions — Business Day” \n	\n
\n Tax redemption: \n	\n Notwithstanding anything to the contrary in the accompanying product supplement, the provisions set forth under “General Terms of the Notes — Payment of Additional Amounts” and “General Terms of the Notes — Tax Redemption” shall not apply to the securities. \n	\n
\n Canadian bail-in: \n	\n The securities are not bail-inable debt securities under the CDIC Act. \n	\n
\n Terms incorporated: \n	\n All of the terms appearing above the item under the caption “General Terms of the Notes” in the accompanying product supplement, as modified by this document, and for purposes of the foregoing, the terms used herein mean the corresponding terms as defined in the accompanying product supplement, as specified below: \n	\n
\n Term used herein \n	\n Corresponding term in the accompanying product supplement \n
\n underlying stock \n	\n reference asset \n
\n stated principal amount \n	\n principal amount \n
\n original issue date \n	\n issue date \n
\n determination dates \n	\n valuation dates \n
\n final determination date \n	\n final valuation date \n
\n contingent quarterly coupon \n	\n contingent coupon \n
\n contingent coupon payment date(s) \n	\n coupon payment date(s) \n
\n closing price \n	\n closing value \n
\n initial share price \n	\n initial value \n
\n call threshold price \n	\n call threshold \n
\n final share price \n	\n final value \n
\n downside threshold price \n	\n barrier value, contingent coupon barrier value \n
\n In addition to those terms, the following two sentences are also so incorporated into the master note: BNS confirms that it fully understands and is able to calculate the effective annual rate of interest applicable to the securities based on the methodology for calculating per annum rates provided for in the securities. BNS irrevocably agrees not to plead or assert Section 4 of the Interest Act (Canada), whether by way of defense or otherwise, in any proceeding relating to the securities. \n	\n
\n Additional information regarding estimated value of the securities: \n	\n On the cover page of this pricing supplement, BNS has provided the initial estimated value for the securities. The initial estimated value was determined by reference to BNS’ internal pricing models, which take into consideration certain factors, such as BNS’ internal funding rate on the pricing date and BNS’ assumptions about market parameters. For more information about the initial estimated value, see “Risk Factors — Risks Relating to Estimated Value and Liquidity” herein. \n The economic terms of the securities (including the contingent quarterly coupon, call threshold price and downside threshold price) are based on BNS’ internal funding rate, which is the rate BNS would pay to borrow funds through the issuance of similar market-linked securities and the economic terms of certain related hedging arrangements. Due to these factors, the issue price you pay to purchase the securities is greater than the initial estimated value of the securities. BNS’ internal funding rate is typically lower than the rate BNS would pay when it issues conventional fixed rate debt securities as discussed further under “Risk Factors — Risks Relating to Estimated Value and Liquidity — Neither BNS’ nor SCUSA’s estimated value of the securities at any time is determined by reference to credit spreads or the borrowing rate BNS would pay for its conventional fixed-rate debt securities”. BNS’ use of its internal funding rate reduces the \n	\n

October 2026 Page 16

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n
\n	\n economic terms of the securities to you. We urge you to read the “Risk Factors” in this pricing supplement for additional information. \n	\n
\n Material Canadian income tax consequences: \n	\n See “Supplemental Discussion of Canadian Tax Consequences” in the accompanying product supplement. \n	\n
\n Tax considerations: \n	\n The U.S. federal income tax consequences of your investment in the securities are uncertain. There are no statutory provisions, regulations, published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the securities. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion in “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the “Code”), final, temporary and proposed U.S. Department of the Treasury (the “Treasury”) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the “IRS”) has been sought as to the U.S. federal income tax consequences of your investment in the securities, and the following discussion is not binding on the IRS. \n U.S. Tax Treatment. Pursuant to the terms of the securities, BNS and you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to characterize the securities as prepaid derivative contracts with respect to the underlying stock. If your securities are so treated, any contingent quarterly coupon that is paid by BNS (including on the maturity date or upon early redemption) should be included in your income as ordinary income in accordance with your regular method of accounting for U.S. federal income tax purposes. \n In addition, you should generally recognize capital gain or loss upon the taxable disposition (including cash settlement) of your securities in an amount equal to the difference between the amount you receive at such time (other than amounts or proceeds attributable to a contingent quarterly coupon or any amount attributable to any accrued but unpaid contingent quarterly coupon) and the amount you paid for your securities. Such gain or loss should generally be long-term capital gain or loss if you have held your securities for more than one year (and, otherwise, short-term capital gain or loss). The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the taxable disposition of your securities prior to a contingent coupon payment date, but that could be attributed to an expected contingent quarterly coupon, could be treated as ordinary income. You should consult your tax advisor regarding this risk. \n Except to the extent otherwise required by law, BNS intends to treat your securities for U.S. federal income tax purposes in accordance with the treatment described above and under “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement unless and until such time as the IRS and the Treasury determine that some other treatment is more appropriate. \n Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver & Jacobson LLP, is of the opinion that it would be reasonable to treat your securities in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the securities, it is possible that your securities could alternatively be treated for tax purposes as a single contingent payment debt instrument or pursuant to some other characterization, such that the timing and character of your income from the securities could differ materially and adversely from the treatment described above, as described further under “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement. \n	\n

October 2026 Page 17

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n

Notice 2008-2. In 2007, the IRS released a notice that may affect the taxation of holders of the securities. According to Notice 2008-2, the IRS and the Treasury are considering whether a holder of an instrument such as the securities should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the securities will ultimately be required to accrue income currently in excess of any receipt of contingent quarterly coupons and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special “constructive ownership rules” of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance and potential impact of the above considerations.

Medicare Tax on Net Investment Income. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their “net investment income,” or “undistributed net investment income” in the case of an estate or trust, which may include any income or gain realized with respect to the securities, to the extent of their net investment income or undistributed net investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult their tax advisors as to the consequences of the 3.8% Medicare tax.

Specified Foreign Financial Assets. Certain U.S. holders that own “specified foreign financial assets” in excess of an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax advisors as to the application of this legislation to their ownership of the securities.

Non-U.S. Holders. The U.S. federal income tax treatment of the contingent quarterly coupons is unclear. Subject to Section 897 of the Code and Section 871(m) of the Code, and FATCA, each as discussed below, we currently do not intend to treat contingent quarterly coupons paid to a non-U.S. holder that provides us (and/or the applicable withholding agent) with a fully completed and validly executed applicable IRS Form W-8 as subject to U.S. withholding tax and we currently do not intend to withhold any tax on contingent quarterly coupons. However, it is possible that the IRS could assert that such payments are subject to U.S. withholding tax, or that another withholding agent may otherwise determine that withholding is required, in which case we or the other withholding agent may withhold up to 30% on such payments (subject to reduction or elimination of such withholding tax pursuant to an applicable income tax treaty). We will not pay any additional amounts in respect of such withholding. Subject to Section 897 of the Code and Section 871(m) of the Code, discussed below, gain realized from the taxable disposition of a security generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by the non-U.S. holder in the U.S., (ii) the non-U.S. holder is a non-resident alien individual and is present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) the non-U.S. holder has certain other present or former connections with the U.S.

Section 897. We will not attempt to ascertain whether the underlying stock issuer would be treated as a “United States real property holding corporation” (“USRPHC”) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the securities should be treated as “United States real property interests” (“USRPI”) as defined in Section 897 of the Code. If any such entity and/or the securities were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a security upon a taxable disposition of the security to U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of the underlying stock issuer as a USRPHC and/or the securities as USRPI.

October 2026 Page 18

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n

Section 871(m). A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain “dividend equivalents” paid or deemed paid to a non-U.S. holder with respect to a “specified equity-linked instrument” that references one or more dividend-paying U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (“delta-one specified equity-linked instruments”) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2029.

Based on our determination that the securities are not “delta-one” with respect to the underlying stock, our special U.S. tax counsel is of the opinion that the securities should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the securities are set. If withholding is required, we will not make payments of any additional amounts.

Nevertheless, after the date the terms are set, it is possible that your securities could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the underlying stock or your securities, and following such occurrence your securities could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the securities under these rules if you enter, or have entered, into certain other transactions in respect of the underlying stock or the securities. If you enter, or have entered, into other transactions in respect of the underlying stock or the securities, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your securities in the context of your other transactions.

Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the securities, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the securities.

FATCA. The Foreign Account Tax Compliance Act (“FATCA”) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on “withholdable payments” (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition of property of a type which can produce U.S.-source interest or dividends) and “passthru payments” (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.

Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain “withholdable payments”, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term “foreign passthru payment” are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.

Proposed Legislation. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of securities similar to the securities purchased after the bill was enacted to accrue interest income over the term of such securities despite the fact that there may be no interest payments over the term of such securities.

October 2026 Page 19

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation generally would have been to require instruments such as the securities to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.

It is not possible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your securities. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your securities.

Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to their particular situations, as well as any tax consequences of the purchase, beneficial ownership and disposition of the securities arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of BNS).

Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any):

SCUSA, our affiliate, has agreed to purchase the securities at the stated principal amount and, as part of the distribution of the securities, has agreed to sell the securities to Morgan Stanley Wealth Management with an underwriting discount of $22.50 reflecting a fixed sales commission of $17.50 and a fixed structuring fee of $5.00 per $1,000.00 stated principal amount of securities that Morgan Stanley Wealth Management sells. BNS or an affiliate may also pay a fee to LFT Securities, LLC, an entity in which an affiliate of Morgan Stanley Wealth Management has an ownership interest, for providing certain electronic platform services with respect to this offering.

BNS, SCUSA or any other affiliate of BNS may use this document, the accompanying product supplement and the accompanying prospectus in a market-making transaction for any securities after their initial sale. In connection with the offering, BNS, SCUSA, any other affiliate of BNS or any other securities dealers may distribute this document, the accompanying product supplement and the accompanying prospectus electronically. Unless BNS or its agent informs the purchaser otherwise in the confirmation of sale, this document, the accompanying product supplement and the accompanying prospectus are being used in a market-making transaction.

Conflicts of Interest — SCUSA is an affiliate of BNS and, as such, has a “conflict of interest” in this offering within the meaning of the Financial Industry Regulatory Authority, Inc. (“FINRA”) Rule 5121. In addition, BNS will receive the gross proceeds from the initial public offering of the securities, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, the offering is being conducted in compliance with the provisions of FINRA Rule 5121. SCUSA is not permitted to sell securities in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.

In the ordinary course of their various business activities, SCUSA, and its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of BNS. SCUSA, and its affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

SCUSA and its affiliates may offer to buy or sell the securities in the secondary market (if any) at prices greater than BNS’ internal valuation — The value of the securities at any time will vary based on many factors that cannot be predicted. However, the price (not including SCUSA’s or any affiliates’ customary bid-ask spreads) at which SCUSA or any affiliate would offer to buy or sell the securities immediately after the pricing date in the secondary market is expected to exceed the initial estimated value of the securities as determined by reference to our internal pricing models. The amount of the excess will decline to zero on a straight line basis over a period ending no later than 6 weeks after the pricing date, provided that SCUSA may shorten the period based on various factors, including the magnitude of purchases and other negotiated provisions with selling agents. Notwithstanding the foregoing, SCUSA and its affiliates intend, but are not required, to make a market for the securities and may stop making a market at any time. For more information about secondary market offers and the initial estimated value of the securities, see “Risk Factors” herein.

October 2026 Page 20

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n
\n Prohibition of sales to EEA retail investors: \n	\n The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of the following: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the “EU PRIIPs Regulation”) for offering or selling the securities or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the securities or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation. \n	\n
\n Prohibition of sales to United Kingdom retail investors: \n	\n The securities are not intended to be offered, sold, distributed or otherwise made available to and should not be offered, sold, distributed or otherwise made available to any retail investor in the United Kingdom (the “UK”). For these purposes, a retail investor means a person who is either one (or both) of the following: (i) not a professional client as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”) or (ii) not a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024. Consequently no disclosure document required by the UK Financial Conduct Authority (the “FCA”) Product Disclosure Sourcebook (“DISC”) for offering, selling or distributing the securities or otherwise making them available to retail investors in the UK has been prepared and therefore offering, selling or distributing the securities or otherwise making them available to any retail investor in the UK may be unlawful under DISC and the Consumer Composite Investments (Designated Activities) Regulation 2024. \n	\n
\n Validity of the securities: \n	\n In the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, as special counsel to BNS, when the securities offered by this pricing supplement have been executed and issued by BNS and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the securities will be valid and binding obligations of BNS, enforceable against BNS in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors’ rights generally, and to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver & Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by Osler, Hoskin & Harcourt LLP, Canadian legal counsel for BNS, in its opinion expressed below. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the indenture and, with respect to the securities, authentication of the securities and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank, Harris, Shriver & Jacobson LLP dated August 28, 2026 filed with the SEC as Exhibit 5.3 to the Registration Statement on Form F-3 on August 28, 2026. \n	\n

October 2026 Page 21

\n \n \n \n \n \n \n \n \n \n \n \n \n

\n \n

$15,138,000 Contingent Income Auto-Callable Securities with Memory Coupon due October 12, 2029

Based on the Performance of the Common Stock of Palantir Technologies Inc.

Principal at Risk Securities

\n \n \n \n \n \n \n \n \n \n \n \n

\n	\n	\n	\n
\n	\n In the opinion of Osler, Hoskin & Harcourt LLP, the issue and sale of the securities has been duly authorized by all necessary corporate action of BNS in conformity with the Indenture, and when the securities have been duly executed, authenticated and issued in accordance with the Indenture, and delivered against payment therefor, the securities will be validly issued and, to the extent validity of the securities is a matter governed by the laws of the Province of Ontario or the federal laws of Canada applicable therein, will be valid obligations of BNS, subject to the following limitations (i) the enforceability of the Indenture may be limited by the Canada Deposit Insurance Corporation Act (Canada), the Winding-up and Restructuring Act (Canada) and bankruptcy, insolvency, reorganization, receivership, preference, moratorium, arrangement or winding-up laws or other similar laws affecting the enforcement of creditors’ rights generally; (ii) the enforceability of the Indenture may be limited by equitable principles, including the principle that equitable remedies such as specific performance and injunction may only be granted in the discretion of a court of competent jurisdiction; (iii) pursuant to the Currency Act (Canada) a judgment by a Canadian court must be awarded in Canadian currency and that such judgment may be based on a rate of exchange in existence on a day other than the day of payment; (iv) the enforceability of the Indenture will be subject to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the Indenture to be unenforceable as an attempt to vary or exclude a limitation period under that Act; and (v) the provisions for the payment of interest (for the purposes of the Criminal Code (Canada)) may be unenforceable if those provisions create an obligation to pay interest in an amount or at a rate prohibited by the Criminal Code (Canada). This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable therein. In addition, this opinion is subject to customary assumptions about the Trustees’ authorization, execution and delivery of the Indenture and the genuineness of signatures and certain factual matters, all as stated in the letter of such counsel dated August 28, 2026, which has been filed as Exhibit 5.2 to BNS’ Form F-3 filed with the SEC on August 28, 2026. \n	\n

October 2026 Page 22

","original","zhKind","translation","complete",false,"BNS","公司与财报","金融","行业与主题","政策与监管","观点与解读","其他","aihot","/items/b0xx3hofa67dbady67dzk5oer","https://www.sec.gov/Archives/edgar/data/9631/000183988226050530/0001839882-26-050530-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1792108800&sig=e4adf00b596060d2","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1792108800&sig=208b33ec2756b0ea 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1792108800&sig=786fcd6a5ff8379c 96w","changelogVersion","2026-10-01T08:00"]